Delivery Order SPE2DB25D3306-SPE2DB25FUCPZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,578.85 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $45,830.70 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,577.37 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a injectable medication used in diabetes management, and this order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with a ceiling value of $1,559.46. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, and this order...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.10 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on July 30, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,441.80 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management within military and federal...
- The Defense Logistics Agency awarded a $5,441.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors (0.5 ml). The contract, which represents a non-set-aside competitive award, is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,026.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This is a non-set-aside competitive award with performance to be completed by July 29, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors (0.5 mL). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCPZDelivery Order
The Defense Logistics Agency awarded a $6,259.89 delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 10 mg/0.5 mL pen injectors on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 8/13/25 |